A real-world data analysis investigating the cardioprotective effects of glucagon-like peptide-1 receptor agonists among people with type 2 diabetes in England
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Midland Metropolitan University Hospital, Smethwick (United Kingdom of Great Britain & Northern Ireland)
8 More presentations in this session
Associate Professor M. Cavender (Chapel Hill, US)
DNA methylation in the TXNIP gene is associated with type 2 diabetes in Pacific Peoples living in NZ
Mr S. Gibbs (Christchurch, NZ)
Professor M. Matshela (Durban, ZA)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
